Loading...
Loading...
If you work in technology, your stock options or RSUs may turn out to be the single largest financial decision of your career — bigger than your salary, bigger than your 401(k), and far more complicated than either. Yet most engineers, product managers, and operators I meet treat equity as an afterthought, a line item they glance at once a year. A deliberate tech employee stock option strategy changes that. It turns a confusing grant letter into a plan you can actually execute, one that accounts for vesting, taxes, concentration risk, and the very different realities of working at a public giant versus a private rocket ship.
The stakes have only risen in 2026. After a frozen IPO window in 2022 and 2023, the public markets reopened — listings like Reddit, Astera Labs, and Klarna proved investors still have appetite for tech, and a deep backlog of unicorns is now testing the waters. At the same time, big-tech grants have ballooned alongside share prices that touched record highs. Whether your equity sits in a Nasdaq-listed mega-cap or a Series C startup, the question is the same: what is your plan? This guide lays out a practical framework, contrasts FAANG stock options vs startup grants, and explains where a tool like equity pooling fits.
Equity compensation has become the default currency of the technology industry. Across senior technical roles, equity routinely makes up a large share of total compensation, and for early startup employees it can dwarf cash entirely. That concentration is the core problem. A thoughtful equity plan is, at its heart, a risk-management exercise: you are deciding how much of your net worth to leave riding on a single employer's fortunes.
I have spent years on the equity-research side of the table, and the pattern I see most often is inertia. People do nothing — they let options sit unexercised until a 90-day post-termination clock forces a panicked, tax-inefficient decision, or they hold vested RSUs in their employer's stock simply because selling feels disloyal. Neither is a strategy. The good news is that a few deliberate choices, made early, tend to compound into meaningful differences in outcome.
Before you can build a plan, you need to understand exactly what you hold. Startup stock and option holders face a genuinely hard problem — illiquid shares, real exercise costs, and binary outcomes. Read your grant documents, confirm whether you have ISOs, NSOs, or RSUs, note your strike price and vesting schedule, and find your most recent 409A valuation. That paperwork is the raw material of every decision that follows.
The phrase "tech equity" papers over a chasm. Comparing FAANG stock options vs startup grants is like comparing a money-market fund to a venture bet — both are "investments," but the risk, liquidity, and tax profiles barely overlap. Understanding the big tech vs startup equity divide is the foundation of any sensible strategy.
At a large public company — Apple, Microsoft, Alphabet, Meta, Nvidia, and their peers — equity almost always arrives as RSUs that vest over four years and convert to freely tradable shares you can sell the moment they vest. Liquidity is immediate, valuation is transparent (just check the ticker), and the main decision is whether to sell on vest or hold. The risk is concentration, not illiquidity: a senior engineer who never sells can end up with the majority of their net worth in one stock.
At a startup, equity usually means options — ISOs or NSOs — with a strike price you must pay to exercise, a 409A valuation instead of a market price, and no liquidity until an acquisition, IPO, or secondary sale. The upside can be life-changing, but the base rate is sobering. Research on venture outcomes consistently shows that a large share of venture-backed startups return little or nothing to common shareholders. That is the real heart of big tech vs startup equity: certainty and liquidity on one side, asymmetric but improbable upside on the other.
None of this is investment advice, but the mechanics are well documented. The U.S. Securities and Exchange Commission's investor education site, Investor.gov, explains the basics of employee stock options and the risks of holding a concentrated position. It is worth ten minutes of reading before you make any move.
A durable tech employee stock option strategy answers five questions in order: What do I own? When does it vest? What will it cost me in cash and taxes to realize it? How concentrated am I? And what is my plan to diversify? Work through them sequentially rather than reacting to whatever email HR sent last.
1. Inventory and timeline. Map every grant, its type, strike price, and vesting dates on a single spreadsheet. Mark the cliff, the monthly vesting cadence, and any expiration or post-termination exercise windows. You cannot plan around dates you have not written down.
2. Model the cost. Exercising startup options costs real money — strike price plus a potential tax bill. For incentive stock options, the spread between strike and fair market value can trigger the alternative minimum tax. Run the numbers before you act; if you need to understand how people actually fund exercises, our guide on how to pay for stock options walks through the realistic paths.
3. Decide your sell-on-vest rule for public stock. If you are at a big-tech employer, the cleanest discipline is to sell RSUs as they vest and reinvest into a diversified portfolio, treating the proceeds like a cash bonus. Holding is a deliberate bet that your employer outperforms the broad market — sometimes right, often not.
4. Stress-test concentration. Ask what happens to your finances if the stock falls 50%. If the honest answer is "catastrophe," you are over-concentrated regardless of how confident you feel about the company.
5. Build a diversification path. This is where startup employees in particular get stuck — their equity is illiquid, so "just sell some" is not on the menu. If you want to pressure-test scenarios first, Aption's Equity Simulator lets you model outcomes across different exit assumptions. We will return to the diversification question below.
Taxes quietly determine how much of your equity you actually keep, and they differ sharply across the big tech vs startup equity divide. RSUs at a public company are taxed as ordinary income at vesting, with shares typically withheld to cover it — simple, if sometimes painful. Startup options are more intricate: NSOs are taxed on the spread at exercise, while ISOs can qualify for favorable long-term capital gains treatment if you meet the holding-period rules, but may generate alternative minimum tax along the way.
The IRS lays out the rules in Publication 525, "Taxable and Nontaxable Income," which covers how different equity awards are treated. Tax outcomes are highly individual, though, and a qualified CPA or tax advisor who knows equity compensation is usually worth far more than they cost. Nothing here is tax advice.
A recurring, expensive mistake: exercising a large block of ISOs late in the year without modeling AMT, then owing a tax bill on paper gains that may never materialize if the company stalls. In my experience, the employees who come out ahead are the ones who treated tax planning as part of their equity strategy from day one, not as a surprise in April.
Whether you arrived here from FAANG stock options vs startup comparisons or you are simply holding too much of one company, the endgame is the same: diversification. For public-company employees, the path is straightforward — sell vested shares over time and spread the proceeds across a broad portfolio, ideally with the help of a financial advisor and an eye on capital-gains timing.
For startup employees the path is harder, because the shares are illiquid and selling on a secondary market can be expensive, restricted, or simply unavailable. This is the gap that equity pooling is designed to fill. Instead of selling your shares outright or betting everything on a single exit, you can pool your equity with employees from other startups and gain diversified exposure to a basket of companies — conceptually, an index fund for startup equity. Our Introduction to Equity Pooling explains the mechanics, and if you are weighing whether to exercise and hold at all, Should I Buy My Equity? is a useful companion read.
Diversification does not eliminate risk, and pooling is not a guaranteed return — no equity strategy is. But spreading a concentrated, illiquid position across many startups changes the shape of your risk in a way that a single grant never can.
The difference between employees who build real wealth from technology equity and those who watch it evaporate rarely comes down to picking the right company. It comes down to having a tech employee stock option strategy at all — knowing what you hold, planning for taxes, and managing concentration before an exit (or a layoff) forces your hand. Start with the inventory, talk to a tax professional, and decide deliberately how much single-company risk you are willing to carry.
If your equity is concentrated in a private startup and you would like to explore diversifying without waiting for an IPO that may never come, you can see what a pooled approach looks like for your specific grant by getting an offer from Aption. It is one more tool in a well-built strategy — not a substitute for professional advice.
Disclaimer: The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. Consult qualified professionals before making financial decisions. Past performance is not indicative of future results, and all investing involves risk, including the possible loss of principal.
Michael is a financial analyst and equity markets researcher who covers startup valuations, secondary markets, and alternative investment vehicles. He previously led equity research at a top-tier investment bank.